Evidence map›Paper›PMID 39477837›Full record

ArticleEuropean radiology2025

Using interpretable deep learning radiomics model to diagnose and predict progression of early AD disease spectrum: a preliminary [

Jiehui Jiang, Chenyang Li, Jiaying Lu, Jie Sun, Xiaoming Sun, Jiacheng Yang, Luyao Wang, Chuantao Zuo, Kuangyu Shi, Alzheimer’s Disease Neuroimaging Initiative

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in European radiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Jiehui Jiang *Institute of Biomedical Engineering, School of Life Sciences, Shanghai University, Shanghai, China. jiangjiehui@shu.edu.cn.ORCID http://orcid.org/0000-0003-4948-3683
Chenyang Li *Institute of Biomedical Engineering, School of Life Sciences, Shanghai University, Shanghai, China.
Jiaying Lu *Department of Nuclear Medicine & PET Center, Huashan Hospital, Fudan University, Shanghai, China.
Jie SunInstitute of Biomedical Engineering, School of Life Sciences, Shanghai University, Shanghai, China.
Xiaoming SunSchool of Communication and Information Engineering, Shanghai University, Shanghai, China.
Jiacheng YangInstitute of Biomedical Engineering, School of Life Sciences, Shanghai University, Shanghai, China.
Luyao WangInstitute of Biomedical Engineering, School of Life Sciences, Shanghai University, Shanghai, China.
Chuantao ZuoDepartment of Nuclear Medicine & PET Center, Huashan Hospital, Fudan University, Shanghai, China. zuochuantao@fudan.edu.cn.
Kuangyu ShiDepartment of Nuclear Medicine, University Hospital Bern, Bern, Switzerland.
Alzheimer’s Disease Neuroimaging Initiative

Funding

National Natural Science Foundation of China 62376150National Natural Science Foundation of China 82020108013Science and Technology Innovation 2030 - Major Projects 2022ZD021606Shanghai Pudong New Area Health Commission PWZxk2022-03
6 · The paper itself

Abstract

objectivesIn this study, we propose an interpretable deep learning radiomics (IDLR) model based on [

methodsThis multicentre study included 1962 subjects from two ethnically diverse, independent cohorts (a Caucasian cohort from ADNI and an Asian cohort merged from two hospitals in China). The IDLR model involved feature extraction, feature selection, and classification/prediction. We evaluated the IDLR model's ability to distinguish between subjects with different cognitive statuses and MCI trajectories (sMCI and pMCI) and compared results with radiomic and deep learning (DL) models. A Cox model tested the IDLR signature's predictive capability for MCI to AD progression. Correlation analyses identified critical IDLR features and verified their clinical diagnostic value.

resultsThe IDLR model achieved the best classification results for subjects with different cognitive statuses as well as in those with MCI with distinct trajectories, with an accuracy of 76.51% [72.88%, 79.60%], (95% confidence interval, CI) while those of radiomic and DL models were 69.13% [66.28%, 73.12%] and 73.89% [68.99%, 77.89%], respectively. According to the Cox model, the hazard ratio (HR) of the IDLR model was 1.465 (95% CI: 1.236-1.737, p < 0.001). Moreover, three crucial IDLR features were significantly different across cognitive stages and were significantly correlated with cognitive scale scores (p < 0.01).

conclusionsPreliminary results demonstrated that the IDLR model based on [ KEY POINTS: Question The study addresses the lack of interpretability in existing DL classification models for diagnosing the AD spectrum. Findings The proposed interpretable DL radiomics model, using radiomics-supervised DL features, enhances interpretability from traditional DL models and improves classification accuracy. Clinical relevance The IDLR model interprets DL features through radiomics supervision, potentially advancing the application of DL in clinical classification tasks.

Indexed as

Alzheimer DiseaseDeep LearningImage Interpretation, Computer-AssistedPositron-Emission TomographyAgedAged, 80 and overCognitive DysfunctionDisease ProgressionFemaleFluorodeoxyglucose F18HumansMaleMiddle AgedRadiomicsRadiopharmaceuticalsFluorodeoxyglucose F18RadiopharmaceuticalsAlzheimer’s diseaseCox modelInterpretable deep learning radiomics modelMild cognitive impairmentRadiomics

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.